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Introduction {#sec1}
============

Treatment for neurological sequelae caused by brain injury or stroke is at present limited to medication and rehabilitation, which have some therapeutic effects but cannot provide fundamental cures. On the other hand, the reconstruction of lost neural circuits by a cell-replacement strategy is expected to be a curative therapy for neurological deficits after cerebral cortex injury ([@bib20]; [@bib30]).

The transplantation of embryonic cerebral cortex tissues is an effective approach to reconstructing damaged neural circuits. Previous studies reported that the transplantation of cerebral cortex tissue of mouse embryo into the cerebral cortex of rodents provided axonal projections from the graft to the host brain and spinal cord, synaptic connections between the graft and the host, and functional recovery of the grafted host ([@bib3]; [@bib17]; [@bib34]). Other studies described the transplantation of human pluripotent stem cell (hPSC)-derived neural stem cells, neuronal progenitor cells, or neurons into rodent cerebral cortices to reconstruct neural circuits ([@bib13], [@bib14]; [@bib33]; [@bib44], [@bib45]).

Cerebral organoids are stem cell-derived structures generated *in vitro* and display the 3D architecture and physiology of the cerebrum ([@bib12]; [@bib24]; [@bib26]; [@bib37]). They are potential tools for modeling cerebrum-related disorders, such as Zika virus-related microcephaly, and for developing treatments ([@bib8]; [@bib9]; [@bib18]; [@bib35]; [@bib46]). Since cerebral organoids have a developmental process similar to that of embryonic cerebral cortex, hPSC-derived cerebral organoids can be a cell source for the restoration of lost neural circuits via transplantation. The transplantation of hPSC-derived cerebral organoids into mouse cerebral cortex has been evaluated for the vascularization of the organoids, the rates of graft survival, and the neuronal differentiation after transplantation ([@bib10]; [@bib31]).

Cerebral organoids recapitulate the process of neurogenesis in the development of the cerebral cortex ([@bib22]; [@bib36]; [@bib42]). *In vivo*, cortical neurogenesis is initiated by rounds of asymmetric divisions of progenitor cells called radial glial cells (RGCs), which form the ventricular zone (VZ) in the apical side of the cerebral cortex. After an asymmetrical division of RGCs, one daughter cell remains as an RGC in the VZ, and the other becomes a neuron or an intermediate progenitor cell. Neurons that migrate out of the VZ form the cortical plate on the basal side of the VZ. Different types of neurons are thought to be generated temporally, and late-born neurons migrate to the basal side of early-born neurons, which results in the unique layer formation of the cerebral cortex with an inside-out pattern ([@bib11]; [@bib21]; [@bib25]; [@bib43]). The deep layer of the cerebral cortex is formed earlier and contains subcerebral projection neurons (SCPNs), which extend axons to the outside of the cerebral cortex, such as the brainstem and the spinal cord. The upper layer is formed later and composed of callosal projection neurons (CPNs), which extend axons to other areas of the cerebral cortex ([@bib28]; [@bib32]; [@bib43]). In mouse embryo, SCPNs are generated at approximately embryonic days (E) 12.5--14.5, and CPNs are generated at approximately E13.5--E16.5 ([@bib15]; [@bib23]; [@bib25]). Previous studies describing the transplantation of embryonic cerebral cortex generally used E14--E15 mouse cerebral cortex tissues as the grafts ([@bib3]; [@bib16], [@bib17]; [@bib34]).

Because the cellular compositions of embryonic cerebral cortex and cerebral organoids dramatically change along the time course of the development, differences in the developmental stages of the graft could greatly affect the results of the transplantation. However, the effect of these differences has not been compared in the transplantation of embryonic cerebral cortex and cerebral organoids. Furthermore, in cerebral organoid transplantation, the effect of the transplantation site, the effect of the host brain environment, and the applicability of the transplantation to primates have not been investigated.

In this study, to clarify which developmental stage of cerebral organoids is suitable for transplantation, we transplanted human embryonic stem cell (hESC)-derived cerebral organoids at early stage (the time of SCPN generation) and late stage (the time of CPN generation) into mouse cerebral cortex and compared the graft survival and axonal extension to the host. We also evaluated the effects of the transplantation site and host brain environment as well as the transplantation of cerebral organoids into the motor cortex of nonhuman primate brain.

Results {#sec2}
=======

Characterization of Cerebral Organoids at Different Developmental Stages {#sec2.1}
------------------------------------------------------------------------

For the induction of cerebral organoids, we adopted the serum-free floating culture of embryoid body-like aggregates with a quick reaggregation method ([@bib12]; [@bib24]) and our previous protocol ([@bib37]) ([Figure 1](#fig1){ref-type="fig"}A). A total of 9,000 dissociated hESCs were put into each well of low-cell-adhesion-coated 96-well plates, where they formed aggregates efficiently after the initiation of differentiation. The formation of several cricoid neuroepithelium-like structures in the aggregates was observed in bright-field images ([Figure 1](#fig1){ref-type="fig"}B). Immunohistochemistry (IHC) analysis of the cerebral organoids at 6 weeks after the initiation of differentiation (6w-organoid) showed the expression of the telencephalic marker FOXG1 ([Figure 1](#fig1){ref-type="fig"}C). 6w-organoids contained the VZ, which was composed of RGC-like cells positive for the dorsal telencephalic progenitor marker PAX6, and cells positive for the neuronal marker MAP2 surrounded the VZ ([Figure 1](#fig1){ref-type="fig"}C). The proliferation marker KI67 was expressed in many cells in the VZ, validating the proliferative activity of RGC-like cells in the VZ ([Figure 1](#fig1){ref-type="fig"}C). Cells positive for the SCPN marker CTIP2 had commenced to form the layer corresponding to the cortical plate while cells positive for the CPN marker SATB2 were not observed ([Figure 1](#fig1){ref-type="fig"}C).Figure 1Characterization of Cerebral Organoids at Different Stages Based on Cellular Components(A) Schematic of the conditions used to induce cerebral organoids from hESCs.(B) Bright-field images of 6w- and 10w-organoids induced from hESCs. Arrowheads: organoids shown in (C). Scale bars, 1 mm.(C) Immunohistochemistry for FOXG1, MAP2, PAX6, CTIP2, KI67, and SATB2 in 6w- and 10w-organoids. In 10w-organoids, the layer of CTIP2^+^ cells was thicker, and SATB2^+^ cells appeared. Right three columns: higher-magnification images of the corresponding boxed areas. Scale bars, 500 μm (left four columns) and 50 μm (right three columns).(D) Thickness of the total epithelium, the layer of PAX6^+^ cells, and the layer of CTIP2^+^ cells in 6w- and 10w-organoids. Average thickness in each aggregate was used for the analysis. n = 10 for 6w-organoids, and n = 13 for 10w-organoids (n, number of aggregates). ^∗∗∗∗^p \< 0.0001; ns, not significant, Mann-Whitney test. Results are presented as the mean ± standard deviation.(E) Percentages of PAX6^+^ cells, KI67^+^ cells, CTIP2^+^ cells, and SATB2^+^ cells in 6w- and 10w-organoids. The whole area of each aggregate was analyzed. n = 10 for 6w-organoids, and n = 13 for 10w-organoids (n, number of aggregates). ^∗∗∗∗^p \< 0.0001, Mann-Whitney test. Results are presented as the mean ± standard deviation.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

In cerebral organoids at 10 weeks after the initiation of differentiation (10w-organoid), the size of neuroepithelium-like structures was larger compared with those of 6w-organoids ([Figure 1](#fig1){ref-type="fig"}B). IHC analysis of the 10w-organoids showed that the thickness of the total epithelium was also increased (6w, 142.1 ± 33.3 μm; 10w, 285.1 ± 28.8 μm) ([Figure 1](#fig1){ref-type="fig"}D). The increase in thickness was more prominent in the layer of CTIP2^+^ cells than in the layer of PAX6^+^ cells, which suggested the robust generation of SCPNs by asymmetric cell division (PAX6^+^ layer, 89.8 ± 17.0 μm \[6w\] and 96.9 ± 8.1 μm \[10w\]; CTIP2^+^ layer, 29.3 ± 8.5 μm \[6w\] and 127.7 ± 22.9 μm \[10w\]) ([Figure 1](#fig1){ref-type="fig"}D). The percentages of PAX6^+^ cells and KI67^+^ cells in total cells of the organoid were lower in 10w-organoids than in 6w-organoids (PAX6, 44.7% ± 4.8% \[6w\] and 24.6% ± 7.1% \[10w\]; KI67, 34.5% ± 5.6% \[6w\] and 12.5% ± 5.4% \[10w\]) ([Figure 1](#fig1){ref-type="fig"}E). In contrast, the percentage of CTIP2^+^ cells was higher in 10w-organoids than in 6w-organoids (6w, 25.5% ± 6.3%; 10w, 46.8% ± 9.3%) ([Figure 1](#fig1){ref-type="fig"}E). SATB2^+^ cells, which were absent in 6w-organoids, were evident in 10w-organoids (6.2% ± 5.1%) ([Figure 1](#fig1){ref-type="fig"}E). When dividing cells were labeled with 5-ethynyl-2′-deoxyuridine (EdU) in 6w-organoids, the EdU^+^ cells contained 5.9% ± 2.2% of CTIP2^+^ cells but no SATB2^+^ cells 1 week after the labeling. In contrast, when dividing cells were labeled in 10w-organoids, the EdU^+^ cells contained more SATB2^+^ cells (2.9% ± 1.0%) than CTIP2^+^ cells (1.8% ± 0.1%) ([Figure S1](#mmc1){ref-type="supplementary-material"}).

These results showed that our culture system could recapitulate the cerebral cortical developmental process, and that 6w-organoids were at a developmental stage before the initiation of CPN generation (early stage) and 10w-organoids were at a developmental stage after the initiation of CPN generation (late stage). We used early- and late-stage organoids as grafts for the transplantations below.

Graft Overgrowth after Transplantation Was Obvious in 6w-Organoids {#sec2.2}
------------------------------------------------------------------

Next, to evaluate whether the difference in the developmental stage of the organoids and the difference in the site of transplantation affected engraftment, we transplanted 6w- or 10w-organoids into the brain of 7-day-old (P7) mice. The organoids at both stages were cut into pieces with 1 mm diameter, each containing 1.9 × 10^5^ cells on average, and the pieces were implanted into the bilateral frontal and parietal cortices ([Figures 2](#fig2){ref-type="fig"}A--2C).Figure 2Graft Overgrowth after Transplantation was Obvious in 6w-Organoids(A) Bright-field images of 6w- and 10w-organoids before and after cutting into pieces. Scale bars, 1 mm.(B) The number of cells contained in 1-mm pieces of 6w- and 10w-organoids. n = 6 for both organoids (n, number of aggregates). ns, not significant; Mann-Whitney test. Results are presented as the mean ± standard deviation.(C) Schematic of the procedure for the transplantation of cerebral organoids into the bilateral frontal and parietal cortices of 7-day-old mice (one piece into each cavity).(D) Immunohistochemistry for hNCAM in sagittal and coronal sections of mouse brains at 12 wpt. Upper left, lateral 1.08 mm; lower left, lateral 1.44 mm; right, Bregma +1.26 mm. Scale bars, 1 mm.(E) The total volume of all survived grafts in each mouse at 12 wpt. n = 8 for each organoid (n, number of mice). ^∗∗∗^p \< 0.001, Mann-Whitney test. Results are presented as the mean ± standard deviation.(F) The total volume of all survived grafts in the frontal or parietal cortices of each mouse at 12 wpt. n = 8 for each organoid (n, number of mice). ns, not significant; Wilcoxon test. Results are presented as the mean ± standard deviation.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

At 12 weeks post-transplantation (wpt), IHC analysis with staining of human neural cell adhesion molecule (hNCAM) revealed the engraftment of 6w- and 10w-organoids in the mouse cerebral cortex ([Figure 2](#fig2){ref-type="fig"}D). 6w-organoids enlarged massively to protrude from the transplanted cavities and spread over the surface of the cerebral cortex. On the other hand, 10w-organoids did not cause massive overgrowth of the grafts ([Figure 2](#fig2){ref-type="fig"}D). Both 6w- and 10w-organoids showed high graft survival rates in both the frontal and parietal cortices (6w, 100%; 10w, 87.5% \[frontal\] and 93.8% \[parietal\]). The total graft volume in each mouse at 12 wpt was significantly larger in 6w-organoids than in 10w-organoids (6w, 34.7 ± 9.4 mm^3^; 10w, 4.9 ± 2.3 mm^3^) ([Figure 2](#fig2){ref-type="fig"}E), but with no difference in the graft volume depending on the site of transplantation ([Figure 2](#fig2){ref-type="fig"}F). There was no difference in the volume of the host brain irrespective of the culture period of the organoids (6w, 190.5 ± 19.5 mm^3^; 10w, 196.8 ± 8.6 mm^3^), suggesting that the grafts grew independent of the developmental process of the brain. Both organoids included endothelial cell marker CD31-positive vessel-like structures, suggesting that the cerebral organoids were vascularized from the host environment after the transplantation ([Figure 3](#fig3){ref-type="fig"}A). There was no difference in the percentage of the CD31^+^ area to total graft area (6w, 0.69% ± 0.07%; 10w, 0.72% ± 0.15%) ([Figure 3](#fig3){ref-type="fig"}B).Figure 3Engrafted Cerebral Organoids Obtained Vascularization from the Host(A) Immunohistochemistry for hNCAM and CD31 in engrafted 6w- and 10w-organoids. Cx, cerebral cortex. The right three columns show higher-magnification images of the boxed areas. Scale bars, 500 μm (leftmost column) and 100 μm (other columns).(B) The percentage of the CD31^+^ area to the hNCAM^+^ area in engrafted 6w- and 10w-organoids. n = 8 for each organoid (n, number of mice). ns, not significant; Mann-Whitney test. Results are presented as the mean ± standard deviation.

In summary, cerebral organoids at both developmental stages had high rates of graft survival with vascularization, but the risk of graft overgrowth appeared higher in 6w-organoids.

Cerebral Projection Neurons Were Observed in Engrafted Cerebral Organoids, but 6w-Organoids Contained a Higher Percentage of Proliferative Cells {#sec2.3}
------------------------------------------------------------------------------------------------------------------------------------------------

Next, we evaluated whether the overgrowth of 6w-organoids after transplantation was related to their proliferative activity. In 6w-organoids at 12 wpt, the existence of PAX6^+^ cells was obvious, and some of these cells co-expressed KI67 ([Figure 4](#fig4){ref-type="fig"}A). In contrast, in 10w-organoids at 12 wpt, PAX6^+^ cells were only present sparsely, and few KI67^+^ cells were observed ([Figure 4](#fig4){ref-type="fig"}A). The percentages of PAX6^+^ cells and KI67^+^ cells in human nuclei (hNuclei)-positive cells were significantly higher in 6w-organoids than in 10w-organoids (PAX6, 18.5% ± 3.8% \[6w\] and 9.8% ± 1.8% \[10w\]; KI67, 5.5% ± 1.0% \[6w\] and 2.0% ± 0.6% \[10w\]) ([Figures 4](#fig4){ref-type="fig"}B, [S2](#mmc1){ref-type="supplementary-material"}A, and S2B), indicating that 6w-organoids contained a significantly higher percentage of proliferative cells than 10w-organoids not only at the time of transplantation but also at 12 wpt.Figure 4Cerebral Projection Neurons Were Observed in Engrafted Cerebral Organoids, but 6w-Organoids Contained a Higher Percentage of Proliferative Cells(A) Immunohistochemistry for hNuclei, PAX6, and KI67 in 6w- and 10w-organoids engrafted in the cerebral cortex (Cx). Right column is a magnification of the white squares. Scale bars, 500 μm (left and middle columns) and 20 μm (right column).(B) Percentages of PAX6^+^ cells and KI67^+^ cells in hNuclei^+^ cells in the engrafted 6w- and 10w-organoids. n = 8 for each organoid (n, number of mice). ^∗∗∗^p \< 0.001, Mann-Whitney test. Results are presented as the mean ± standard deviation.(C) Immunohistochemistry for CTIP2, SATB2, and PAX6 in the engrafted 6w- and 10w-organoids. Right column is a magnification of the white squares. Scale bars, 500 μm (left column) and 20 μm (right column).(D) Percentages of CTIP2^+^ cells and SATB2^+^ cells in hNuclei^+^ cells in the engrafted 6w- and 10w-organoids. n = 8 for each organoid (n, number of mice). ^∗∗∗^p \< 0.001, Mann-Whitney test. Results are presented as the mean ± standard deviation.See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

To reconstruct host neural circuits by cerebral organoid transplantation, projection neurons are required. Therefore, we next evaluated whether projection neurons existed in the engrafted cerebral organoids. Both 6w- and 10w-organoids contained CTIP2^+^ cells and SATB2^+^ cells at 12 wpt ([Figure 4](#fig4){ref-type="fig"}C), and both contained more SATB2^+^ cells than CTIP2^+^ cells in hNuclei^+^ cells ([Figures 4](#fig4){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}C). The percentage of CTIP2^+^ cells in hNuclei^+^ cells was significantly higher in 6w-organoids (6w, 15.3% ± 2.9%; 10w, 4.4% ± 1.3%). In contrast, the percentage of SATB2^+^ cells in hNuclei^+^ cells was significantly higher in 10w-organoids (6w, 48.8% ± 2.3%; 10w, 63.8% ± 8.0%).

In summary, both 6w- and 10w-organoids that engrafted in the cerebral cortex contained graft-derived projection neurons, including CTIP2^+^ SCPNs and SATB2^+^ CPNs, but 6w-organoids contained a higher percentage of proliferative cells, which might explain the graft overgrowth.

6w-Organoids Extended a Larger Number of Axons along the Host Corticospinal Tract {#sec2.4}
---------------------------------------------------------------------------------

Since cerebral organoids that engrafted in the mouse cerebral cortex contained projection neurons, we investigated how the engrafted cerebral organoids extended axons to the host brain. Both 6w- and 10w-organoids in the frontal cortex extended hNCAM^+^ fibers to the surrounding cerebral cortex, the corpus callosum (CC), and the striatum (Str) of the host ([Figure 5](#fig5){ref-type="fig"}A). In addition, both organoids that engrafted in the parietal cortex extended hNCAM^+^ fibers to the surrounding cerebral cortex and CC of the host ([Figure 5](#fig5){ref-type="fig"}B).Figure 56w-Organoids Extended More Axons along the Host CST(A) Immunohistochemistry for human hNCAM after the transplantation of 6w- and 10w-organoids into the frontal cortex (sagittal section) shows graft-derived axonal extensions to the cerebral cortex (Cx), corpus callosum (CC), and striatum (Str). Scale bars, 200 μm.(B) Immunohistochemistry for hNCAM after the transplantation of 6w- and 10w-organoids into the parietal cortex (coronal section) shows graft-derived axonal extensions to the Cx and CC. Scale bars, 200 μm.(C) Schematic showing sagittal sections of mouse brains, including the (1) Str, (2) internal capsule (IC) and cerebral peduncle (CP), and (3) contralateral spinal cord (SC), and IHC for hNCAM showing graft-derived axonal extensions along the host CST after the transplantation of 6w- and 10w-organoids. Scale bars, 100 μm (left three columns) and 20 μm (rightmost column).(D) Number of hNCAM^+^ axons in the Str, IC, CP, and SC of the host after the transplantation of 6w- and 10w-organoids. 6w-organoids provided significantly more axons along the host CST. Average numbers in both hemispheres in each mouse were used for the analyses. n = 8 for each organoid (n, number of mice). ^∗^p \< 0.05, ^∗∗^p \< 0.01, Mann-Whitney test. Results are presented as the mean ± standard deviation.See also [Figures S3--S5](#mmc1){ref-type="supplementary-material"}.

When we evaluated the extension of graft-derived axons along the corticospinal tract (CST) of the host, hNCAM^+^ fibers from both organoids reached the internal capsule (IC), the cerebral peduncle (CP), and the cervical spinal cord (SC), confirming axonal projections along the host CST ([Figure 5](#fig5){ref-type="fig"}C). In Str, hNCAM^+^ fibers were extended along myelin basic protein-positive fasciculated bundles, in which SCPN axons are known to travel in rodents ([Figure S3](#mmc1){ref-type="supplementary-material"}) ([@bib39]). There was no obvious difference in the direction of axonal extensions between 6w- and 10w-organoids, but 6w-organoids provided more fibers along the host CST than 10w-organoids ([Figure 5](#fig5){ref-type="fig"}D). It is possible that the higher number of axons was due to a higher number of surviving cells in the grafts derived from 6w-organoids. Therefore, we normalized the number of axons to the number of hNuclei^+^ and CTIP2^+^ cells in the grafts. Although the number of axons per hNuclei^+^ cell was higher in 6w-organoids ([Figure S4](#mmc1){ref-type="supplementary-material"}A), there was no difference in the number of axons per hNuclei^+^CTIP2^+^ cell in the Str, CP, and SC ([Figure S4](#mmc1){ref-type="supplementary-material"}B).

These data suggested that both 6w- and 10w-organiods had the ability to provide axonal extensions along the host CST but the number of axons was higher in 6w-organoids, and that CTIP2^+^ cells in the graft contributed to the axonal extension along the CST.

6w-Organoids Extended More Axons but Caused Overgrowth in Injured Adult Brain {#sec2.5}
-----------------------------------------------------------------------------

Above, we observed that cerebral organoids extended axons along the CST in the intact brains of P7 mice, but these effects were not confirmed in adult or injured brains. Therefore, we next transplanted 6w- and 10w-organoids into the frontal cortex of 6-week-old mice 1 week after lesioning ([Figure S5](#mmc1){ref-type="supplementary-material"}A). A cavity was made in the right frontal cortex, including the motor area, and a 1-mm piece of organoids was implanted 1 week later.

The graft volume at 12 wpt was significantly larger in 6w-organoids than in 10w-organoids (6w, 27.0 ± 17.7 mm^3^; 10w, 6.7 ± 5.2 mm^3^) ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). So too were the percentages of PAX6^+^ cells and KI67^+^ cells in hNuclei^+^ cells (PAX6, 13.6% ± 5.1% \[6w\] and 7.0% ± 3.4% \[10w\]; KI67, 4.7% ± 1.1% \[6w\] and 2.6% ± 1.1% \[10w\]) ([Figures S5](#mmc1){ref-type="supplementary-material"}D, S5E, and [S6](#mmc1){ref-type="supplementary-material"}A). The percentage of CTIP2^+^ cells in hNuclei^+^ cells was significantly higher in 6w-organoids, while that of SATB2^+^ cells was higher in 10w-organoids (CTIP2, 21.2% ± 8.5% \[6w\] and 8.3% ± 2.9% \[10w\]; SATB2, 48.7% ± 9.5% \[6w\] and 66.6% ± 7.0% \[10w\]) ([Figures S5](#mmc1){ref-type="supplementary-material"}F, S5G, and [S6](#mmc1){ref-type="supplementary-material"}A). In addition, we observed extensions of hNCAM^+^ fibers along the host CST in both groups ([Figure S5](#mmc1){ref-type="supplementary-material"}H), but 6w-organoids provided a significantly larger number of axons to the host IC and CP ([Figure S5](#mmc1){ref-type="supplementary-material"}I).

In summary, as in the case of transplantation into P7 mice, 6w-organoids extended a higher number of axons along the host CST but caused graft overgrowth with more proliferative cells in the injured brain of 6-week-old mice.

Axonal Extensions from 10w-Organoids Were Enhanced by Delayed Transplantation after Lesioning {#sec2.6}
---------------------------------------------------------------------------------------------

In the transplantation of embryonic cerebral cortex, transplantation 1 week after lesioning in the host cerebral cortex promotes axonal extensions from the graft to the host brain rather than transplantation immediately after lesioning ([@bib34]). We therefore considered that if the cerebral organoids had properties similar to embryonic cerebral cortex, then a 1-week delay could enhance axonal extensions even using 10w-organoids, which provided less axonal growth compared with 6w-organoids. To test this hypothesis, we prepared two groups of transplantation of 10w-organoids into 6-week-old mice: transplantation immediately after lesioning (no-delay group) and 1 week after lesioning (1w-delay group) ([Figure 6](#fig6){ref-type="fig"}A), and compared the results of the transplantation between the two groups.Figure 6Axonal Extensions from 10w-Organoids were Enhanced by Delayed Transplantation(A) Schematic of the procedure for the transplantation of 10w-organoids into the frontal cortex of 6-week-old mice with or without 1-week (1w) delay after lesioning. n = 6 for both groups (n, number of mice).(B) Immunohistochemistry for hNCAM in coronal sections of mouse brains at 12 wpt with or without 1w delay. Bregma +0.18 mm. Scale bars, 1 mm.(C) The graft volume at 12 wpt. All mice with graft survival were analyzed (n = 4 for no-delay group, and n = 6 for 1w-delay group). ^∗∗^p \< 0.01, Mann-Whitney test. Results are presented as the mean ± standard deviation.(D) Immunohistochemistry for hNCAM and CD31 in engrafted tissues. The right three columns show higher-magnification images of the boxed areas. Scale bars, 500 μm (leftmost column) and 100 μm (other columns).(E) Percentage of the CD31^+^ area to the hNCAM^+^ area in the engrafted tissues. n = 4 for no-delay group, and n = 6 for 1w-delay group (n, number of mice). ns, not significant; Mann-Whitney test. Results are presented as the mean ± standard deviation.(F) Immunohistochemistry for hNuclei, PAX6, and KI67 in the engrafted tissues at 12 wpt with or without 1w delay. Scale bars, 500 μm.(G) Percentages of PAX6^+^ cells and KI67^+^ cells in hNuclei^+^ cells in the engrafted tissues at 12 wpt with or without 1w delay. n = 4 for no-delay group, and n = 6 for 1w-delay group (n, number of mice). ns, not significant; Mann-Whitney test. Results are presented as the mean ± standard deviation.(H) Immunohistochemistry for CTIP2, SATB2, and PAX6 in the engrafted tissues at 12 wpt with or without 1w delay. Scale bars, 500 μm.(I) Percentages of CTIP2^+^ cells and SATB2^+^ cells in hNuclei^+^ cells at 12 wpt with or without 1w delay. n = 4 for no-delay group, and n = 6 for 1w-delay group (n, number of mice). ns, not significant; Mann-Whitney test. Results are presented as the mean ± standard deviation.(J) Immunohistochemistry for hNCAM in sagittal sections of mouse brain shows graft-derived axonal extensions in the striatum (Str), internal capsule (IC), and cerebral peduncle (CP) of the host at 12 wpt with or without 1w delay. Scale bars, 100 μm.(K) Number of hNCAM^+^ fibers in the Str, IC, and CP of the host at 12 wpt with or without 1w delay. n = 4 for no-delay group, and n = 6 for 1w-delay group (n, number of mice). ^∗∗^p \< 0.01, Mann-Whitney test. Results are presented as the mean ± standard deviation.See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

The graft survival rate at 12 wpt was higher in the 1w-delay group than the no-delay group (no-delay, 66.7%; 1w-delay, 100%). Furthermore, the graft volume was significantly larger in the 1w-delay group than in the no-delay group (no-delay, 1.1 ± 0.6 mm^3^; 1w-delay, 6.4 ± 1.8 mm^3^) ([Figures 6](#fig6){ref-type="fig"}B and 6C). However, there was no significant difference in the volume of the host brain (no-delay, 219.2 ± 15.5 mm^3^; 1w-delay, 210.9 ± 10.5 mm^3^), in the percentage of the CD31^+^ area to total graft area (no-delay, 0.62% ± 0.20%; 1w-delay, 0.76% ± 0.13%) ([Figures 6](#fig6){ref-type="fig"}D and 6E), in the percentages of PAX6^+^ cells and KI67^+^ cells in hNuclei^+^ cells (PAX6, 9.7% ± 3.3% \[no-delay\] and 10.5% ± 3.5% \[1w-delay\]; KI67, 2.7% ± 1.6% \[no-delay\] and 1.9% ± 0.9% \[1w-delay\]) ([Figures 6](#fig6){ref-type="fig"}F, 6G, and [S6](#mmc1){ref-type="supplementary-material"}B), or in the percentages of CTIP2^+^ cells and SATB2^+^ cells in hNuclei^+^ cells (CTIP2, 11.3% ± 5.1% \[no-delay\] and 10.4% ± 4.5% \[1w-delay\]; SATB2, 70.8% ± 4.1% \[no-delay\] and 60.9% ± 6.1% \[1w-delay\]) ([Figures 6](#fig6){ref-type="fig"}H, 6I, and [S6](#mmc1){ref-type="supplementary-material"}B). In both groups, the grafts extended axons along the host CST ([Figure 6](#fig6){ref-type="fig"}J), but there was a significantly larger number of hNCAM^+^ fibers in the 1w-delay group than in the no-delay group ([Figure 6](#fig6){ref-type="fig"}K).

In summary, as in the case of transplanting embryonic cerebral cortex, a 1-week delay between lesioning and transplantation enhanced axonal extensions from the 10w-organoids to the host brain, suggesting that neural circuit reconstruction after cerebral organoid transplantation could be promoted by modulating the environment of the host brain.

Cerebral Organoids Extended Axons in the Brains of Nonhuman Primates {#sec2.7}
--------------------------------------------------------------------

Finally, we investigated whether the transplantation of cerebral organoids could be applied to primates. From an ethical point of view, we transplanted hESC-derived 10w-organoids, which had a lower risk of overgrowth that causes compression of the host brain than 6w-organoids, into the cerebral cortex of cynomolgus monkeys. In order not to affect the higher brain functions of the monkeys, we transplanted cerebral organoids only into the bilateral precentral gyrus, namely the primary motor cortex ([Figure 7](#fig7){ref-type="fig"}A).Figure 7Transplantation of 10w-Organoids into Monkey Cerebral Cortex(A) Axial (left) and coronal (middle) T2-weighted images (T2WI) and coronal T1-weighted image (T1WI) immediately after the transplantation. Arrows mark the site of the transplantation. Scale bars, 5 mm.(B) Coronal T2WI and T1WI at 12 wpt, and immunohistochemistry for STEM121 in coronal sections of monkey brain. Scale bars, 5 mm.(C) Immunohistochemistry for STEM121, TUJ1, PAX6, CTIP2, and SATB2 in the engrafted tissue in monkey cerebral cortex. Scale bars, 1 mm (except inset) and 20 μm (inset).(D) Percentages of PAX6^+^ cells, KI67^+^ cells, CTIP2^+^ cells, and SATB2^+^ cells in intragraft cells at 12 wpt. n = 2 (n, number of monkeys).(E) Immunohistochemistry for TUJ1 and CD31 in the engrafted tissue and the host cerebral cortex. The right three columns show higher-magnification images of the boxed areas. Scale bars, 1 mm (leftmost column) and 100 μm (other columns).(F) The percentage of the CD31^+^ area to total graft area. n = 2 (n, number of monkeys).(G) Immunohistochemistry for STEM121 shows graft-derived axonal extensions to the cerebral cortex and in the subcortical tissues toward the corpus callosum and striatum. Scale bars, 5 mm (low magnification images) and 100 μm (high magnification images).See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

10w-Organoids survived in the cerebral cortex bilaterally in two out of four monkeys at 12 wpt. In the other two monkeys, no graft survival was observed. Using magnetic resonance imaging (MRI), we identified engrafted tissues as regions with high intensity on T2-weighted images and with low intensity on T1-weighted images. There was no obvious overgrowth of cerebral organoids in any monkey ([Figure 7](#fig7){ref-type="fig"}B).

Using IHC analysis, we detected the engraftment of hESC-derived cerebral organoids using the human-specific cytoplasm marker STEM121 ([Figures 7](#fig7){ref-type="fig"}B and 7C). Engrafted tissues entirely expressed the neuronal marker TUJ1 ([Figure 7](#fig7){ref-type="fig"}C). As was the case of transplantation into mouse cerebral cortex, the engrafted tissues contained more SATB2^+^ cells than PAX6^+^ cells, KI67^+^ cells, and CTIP2^+^ cells in monkey primary cortex (PAX6, 9.4%; KI67, 2.7%; CTIP2, 6.1%; SATB2, 60.6%) ([Figures 7](#fig7){ref-type="fig"}C and 7D). We observed CD31^+^ vessel-like structures in the graft, suggesting that the cerebral organoids obtained vascularization in the monkey brains ([Figures 7](#fig7){ref-type="fig"}E and 7F). IHC analysis with a mouse-specific CD31 antibody and a human/monkey-specific CD31 antibody suggested that the blood vessels in the grafts were derived from the host brain ([Figure S7](#mmc1){ref-type="supplementary-material"}). Engrafted 10w-organoids extended STEM121^+^ fibers to the brains of the host monkeys. The STEM121^+^ fibers reached the neighboring cerebral cortical area as well as the subcortical tissue. There were also extensions of STEM121^+^ fibers in the subcortical tissue both toward the CC and Str ([Figure 7](#fig7){ref-type="fig"}G), but there were no fiber extensions in more distal parts, such as the IC or CP.

Taken together, hESC-derived cerebral organoids survived in the cerebral cortex of monkeys and provided axonal extensions along the callosal projection and the subcerebral projection, which suggested that cerebral organoid transplantation could be a useful approach for reconstructing neural circuits after cerebral cortex injury in primates.

Discussion {#sec3}
==========

In this study, we compared the graft volume and axonal extensions along the host CST after transplanting hESC-derived cerebral organoids at two developmental stages. One was the early stage (6w) before the initiation of CPN generation (SCPN-generating stage), and the other was the late stage (10w) after the initiation of CPN generation (CPN-generating stage). We found that the 6w-orgnoids extended a larger number of axons along the host CST, but that they also showed graft overgrowth. In addition, axonal extensions were enhanced in the brain 1 week after brain injury compared with just after the injury. Finally, cerebral organoids survived and extended axons after transplantation into monkey brain.

There are two reports regarding the transplantation of human cerebral organoids into animal brains, but axonal extensions from the organoids along the host CST have never been described. One report showed the vascularization of the organoids with integration to the host brain after transplantation in the mouse retrosplenial cortex ([@bib31]). The other compared 3D cerebral organoids and 2D culture-derived cells in terms of graft survival and neuronal differentiation in the mouse frontoparietal cortex ([@bib10]). In this study, we demonstrated that human cerebral organoids grafted in the mouse frontal cortex extended axons along the CST, suggesting their potential for reconstruction of the host motor pathway.

In the cerebral cortex, SCPNs, which constitute the CST, express CTIP2 ([@bib2]) but not SATB2 ([@bib1]; [@bib5]; [@bib15]). It is reported that in the transplantation of dissociated cerebral cortices from mouse embryos, graft-derived cells that extended axons along the host CST are also CTIP2^+^/SATB2^−^ ([@bib47]). In our study, 6w-organoids, which contained more CTIP2^+^ cells than did 10w-organoids at 12 wpt, extended more axons along the host CST, but there was no significant difference in the number of axons per graft-derived CTIP2^+^ cell in the Str, CP, or SC. These results suggest that CTIP2^+^ cells in the graft play a pivotal role in reconstruction of the CST. It remains unclear, however, what stage of cells in the organoids contributed to the axonal extensions. We suspect two candidates: one is projection neurons that already exist in the graft at the time of transplantation, and the other is immature cells that become projection neurons after the transplantation. In a previous report, graft-derived axons along the host CST were provided by cells that were already post-mitotic at the time of transplantation ([@bib47]). In this study, compared with 10w-organoids, 6w-organoids contained less CTIP2^+^ cells at the time of transplantation, but provided more CTIP2^+^ cells with a larger number of axons after transplantation. This result might suggest that more post-transplant-generated CTIP2^+^ cells became projection neurons, which extended axons along the CST, compared with already-existing CTIP2^+^ cells.

In cell transplantation toward clinical application, graft overgrowth must be avoided because it causes compression or destruction of the host brain. However, the risk of graft overgrowth has not been investigated in cell transplantations aimed at cerebral cortex repair. We found that 10w-organoids, which are in the CPN-generating stage, have a lower risk of graft overgrowth. In previous studies describing the transplantation of embryonic cerebral cortex, E14--E15 mice, which corresponds to the CPN-generating stage, were used as the grafts ([@bib3], [@bib4]; [@bib16], [@bib17]; [@bib34]), which would explain why graft overgrowth did not become a problem in those studies.

The observed enhancement of the graft survival and axonal extensions of 10w-organoids by delaying the transplantation 1 week after the cortical resection suggests that adjusting the host brain environment is a possible approach to promoting axonal extensions from cerebral organoids. Our result is in agreement with a previous study that examined embryonic cerebral cortex ([@bib34]). However, the mechanism through which the host brain 1 week after the resection supports cell survival and axonal extension is unknown. Previous studies suggest that the secretion of pro-angiogenic factors by cells surrounding the lesion ([@bib41]) or the modulation of inflammatory responses ([@bib4]; [@bib29]) are candidates. It is reported that transplantation with 1-week delay provided a transient increase in graft vascularization 4 days after the transplantation ([@bib34]). In our study, a 1-week delay did not cause an obvious difference in the graft vascularization at 12 wpt, but a transient increase in the graft vascularization might have contributed to the enhancement of axonal extensions.

There are substantial differences in the nervous systems between rodents and primates in terms of size and neuroanatomical characteristics ([@bib7]). For example, in rodents, CST fibers descending in the spinal cord travel mostly in the dorsal columns and have no direct connections to motor neurons. In contrast, in primates, CST fibers in the spinal cord travel mostly in the lateral columns and have both direct and indirect connections to motor neurons ([@bib7]; [@bib27]). Such differences can limit the translation of the results obtained from rodents into treatment for human patients ([@bib7]). Therefore, when considering clinical application, primate transplantation models are necessary. One report more than 30 years ago transplanted allogenic embryonic cerebral cortex tissues into the brain of rhesus monkeys, but no graft survival was observed in the cerebral cortex ([@bib19]). The current study clearly showed that the transplantation of hPSC-derived cells into the primate cerebral cortex resulted in graft survival and axonal extensions. The axons, however, were observed only in the subcortical area, probably because a 12-week observation is too short when considering the size of monkey brains. Observation over longer periods is needed to confirm axonal extensions for longer distances.

Ethical issues need to be considered in experiments in which human cells are transplanted into the cerebral cortex of animals ([@bib6]). In this study, to avoid the risk of manipulating the higher brain functions of monkeys by transplantation, we limited the transplantation site to the motor cortex. In addition, to avoid the risk of graft overgrowth compressing the monkey brain, only 10w-organoids were transplanted. Furthering this type of research will include ethical concerns, such as whether the animals can be humanized by creating brain chimeras and whether the cerebral organoids *in vitro* can have consciousness ([@bib40]).

Optimization of both the donor cells and host brain environment is critical for successful transplantations. We have shown that early-stage organoids extend more axons but cause graft overgrowth. Elimination of the proliferating cells by sorting may solve this problem ([@bib38]). In parallel, the clarification and administration of supportive factors may enhance graft survival and axonal extensions. Stepwise solution of these issues will open the way to the realization of a cell-based therapy for brain injury and stroke.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

All animal experiments described in this study were approved by the Institutional Animal Care and Use Committee of the Animal Research Facility at Kyoto University. All animals were cared for and handled in accordance with the Regulation on Animal Experimentation at Kyoto University.

SCID mice (C.B-17/IcrHsd-Prkdcscid, Shimizu Laboratory Supplies) 7 days (male and female, n = 16) and 6 weeks (male, n = 22) old, and purpose-bred male cynomolgus monkeys (*Macaca fascicularis*, Shin Nippon Biomedical Laboratories, n = 4) 3 years old, were used as the transplant recipients. All mice and monkeys were kept on a 12-h light/dark cycle with *ad libitum* access to food and water.

Surgical Procedure for Mice {#sec4.2}
---------------------------

All surgical procedures for mice were performed under anesthesia with isoflurane inhalation. In 7-day-old mice, cerebral organoids were transplanted into the bilateral frontal and parietal cortices immediately after making cavities in the cerebral cortices. Half of the mice (n = 8) received 6w-organoids and the other half (n = 8) received 10w-organoids. A skin incision was performed, and 2 × 2 mm craniotomy windows were opened with bone flaps hinged on the lateral base. A cavity of 1 mm diameter and 1 mm depth was made by aspirating the cortical tissue in each craniotomy window. Cerebral organoids were cut into 1-mm-diameter pieces using micro-scissors (Bio Research Center, no. 16324319), and one piece was implanted into each cavity. The craniotomy window was closed by returning the bone flap, and the skin was sutured with 7-0 ETHILON (Ethicon). In 6-week-old mice, 1-mm pieces were transplanted into the right frontal cortex 1 week after (n = 16) or immediately after (n = 6) making the cavity.

Surgical Procedure for Monkeys {#sec4.3}
------------------------------

All surgical procedures for monkeys were performed under anesthesia with an intramuscular injection of ketamine (10 mg/kg) and xylazine (1 mg/kg). Bilateral precentral gyri were identified by preoperative MRI, and the coordinates of the targets were obtained. A midline skin incision was performed, and 10-mm burr holes were made above the bilateral precentral gyri based on the coordinates obtained from the preoperative MRI. The dura mater was incised, and a 2-mm cavity was made in the precentral cortex. 10w-Organoids were cut into 1-mm pieces, and 3, 5, or 11 pieces were implanted into each cavity. The dura mater and epicranial aponeurosis were sutured with 4-0 NUROLON (Ethicon), and the skin was sutured with 4-0 NESCOSUTURE (alfresa).

An antibiotic (cefazolin sodium; Astellas Pharma) was administered for 3 days from the day of the operation (70 mg/body, intramuscularly). An immunosuppressant (Tacrolimus hydrate; Towa Pharmaceutical, prepared at 5 mg/mL in ethanol and polyoxyethylene hydrogenated castor oil 60) was administered from 1 day before transplantation until the day of euthanization (0.05--0.075 mg/kg, intramuscularly). The blood trough concentration of Tacrolimus was monitored and maintained at 10--25 ng/mL, with blood sampling once every week until the blood concentration reached within the target range followed by blood sampling at 4, 8, and 12 wpt.

Data Acquisition {#sec4.4}
----------------

Images were obtained using a confocal laser microscope (LSM710 and LSM800, Zeiss), except images for quantitative analyses and images of wide fields ([Figures 2](#fig2){ref-type="fig"}B, [5](#fig5){ref-type="fig"}B, [6](#fig6){ref-type="fig"}B, and [7](#fig7){ref-type="fig"}B, left two images of [7](#fig7){ref-type="fig"}C, and lower-magnification images of [7](#fig7){ref-type="fig"}G), which were obtained using a confocal quantitative image cytometer (CQ1; Yokogawa).

Statistical Analysis {#sec4.5}
--------------------

Statistical analyses were performed with PRISM software (GraphPad, version 8). Statistical significances in two-group comparisons were tested with the Mann-Whitney test (unpaired, nonparametric), except the comparison of graft volume in the mouse frontal and parietal cortices ([Figure 2](#fig2){ref-type="fig"}D), which was tested with the Wilcoxon test (paired, nonparametric). The results are expressed as the mean ± standard deviation.
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